Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients
Not Applicable
Terminated
- Conditions
- Corneal Ulcer
- Interventions
- Procedure: NSS/LidocaineProcedure: Lidocaine/NSS
- Registration Number
- NCT00789646
- Lead Sponsor
- Mahidol University
- Brief Summary
The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
-
The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features.
- corneal epithelial defect with stromal infiltration
- reaction in anterior chamber
- positive for bacteria or fungus
-
The patients have to receive subconjunctival antibiotic injection twice at least.
-
The patients must be informed consent.
Exclusion Criteria
- The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs.
- The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection.
- Unable to cooperate with the treatment.
- Pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description NSS/Lidocaine NSS/Lidocaine First injection: Normal saline Second injection: 2% Lidocaine without adrenaline Lidocaine/NSS Lidocaine/NSS First injection: 2% Lidocaine without adrenaline Second injection: Normal saline
- Primary Outcome Measures
Name Time Method Numeric rating scale immediately after injection
- Secondary Outcome Measures
Name Time Method Side effects 24 hours after injection